JATT II Acquisition Corp IPO Closes
Analysis based on 7 articles · First reported Apr 16, 2026 · Last updated Apr 20, 2026
The successful IPO of JATT II Acquisition Corp provides new capital for potential mergers and acquisitions, particularly in the biotechnology and healthcare sectors, which could lead to increased activity and investment in these industries. The listing on Nasdaq also offers a new investment opportunity for market participants.
JATT II Acquisition Corp, a blank check company, announced the closing of its initial public offering on April 20, 2026, raising $60,000,000 by offering 6,000,000 ordinary shares at $10.00 each. The shares began trading on the Nasdaq Global Market under the ticker symbol 'JATT' on April 17, 2026. Guggenheim Partners, LLC served as the sole book-running manager for the offering. The United States===United States Securities and Exchange Commission declared the registration statement effective on April 16, 2026. JATT II Acquisition Corp, sponsored by JATT Ventures II L.P. and led by CEO Someit Sidhu and CFO Nicholas Fernandez, intends to pursue business combinations with healthcare and biotechnology companies, leveraging its management's experience in these fields.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard